Arx
Yehuda Leibler
President & CTO, Arx.
PolyPid partners with Azurity to commercialize D-PLEX100 in the U.S. and Canada
Nuvectis Pharma completes $100 million public offering
Nuvectis expands pipeline with Haisco license for two clinical-stage compounds
From Trump’s Post to SEC Policy: Could U.S. Firms Shift to Twice-Yearly Reporting?
Report: Proposed Changes to Nasdaq Listing Standards
Sarepta’s Collapse Is a Case Study in the High Cost of Withholding Trust
Facing the Storm: GameStop Mania Crystalizes the Importance of Data for Modern Public Companies
The Capital Markets have turned into a landmine for traded companies
Special Update & Report: The SEC’s new SPAC Rules
How Generative AI Is Going to Change the Capital Markets
